{
  "name": "OrSight Pharma",
  "description": "Orsight Pharma is at the forefront of developing an innovative drug for Neovascular Age-Related Macular Degeneration (nAMD or wet AMD), an advanced form of eye disease that is the leading cause of severe vision loss and blindness in developed countries.",
  "categoryId": 12,
  "size": "xs",
  "logoFile": "logos/orsight_pharma-logo.webp",
  "websiteUrl": "https://ngt-healthcare2.com/orsight-pharma",
  "careersUrl": null,
  "linkedinId": null,
  "linkedinNum": null,
  "crunchbaseId": null,
  "ivcId": "A1000000463972",
  "finderId": null,
  "xId": null,
  "facebookId": null,
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": "ואדי אל חאג'",
      "houseNumber": 13,
      "city": "נצרת",
      "lat": 32.6909945,
      "lon": 35.2999996
    }
  ],
  "isMultinational": false,
  "isActive": true
}